Serodiagnosis and Immunotherapy in Infectious Disease
Volume 5, Issue 4, December 1993, Pages 251-252
Short communicationSeroepidemiology and virology of HTLV-1 in the city of Mashhad, northeastern Iran
References (6)
- et al.
Prevalence of human T-cell leukaemia-lymphoma virus (HTLV) type II infection among high risk individuals: type specific identification of HTLVs by polymerase chain reaction
Blood
(1989) - et al.
Antibodies to adult T-cell leukaemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide seroepidemiologic study
Int J Cancer
(1982) Serological and molecular survey for HTLV-1 infection in a high-risk Middle Eastern group
Lancet
(1990)
There are more references available in the full text version of this article.
Cited by (21)
Infection with human T-lymphotropic virus types-and -(HTLV-and -2): Implications for blood transfusion safety
2016, Transfusion Clinique et BiologiqueCitation Excerpt :A recent study in South Africa found a prevalence of 0.16% in low-risk black blood donors, suggesting prevalence in the general black population of perhaps 1% [28]. Surveys in the Middle East have not revealed endemic HTLV-1 with the exception of northeastern Iran (Mashhad) and emigrants from that area now residing in Israel and New York [29]. In northeastern Iran, 0.14% of blood donors were found to be seropositive for HTLV-1 [30].
Human T-Lymphotropic Virus (HTLV)
2014, Mandell, Douglas, and Bennett's Principles and Practice of Infectious DiseasesPathogenicity and virulence of human T lymphotropic virus type-1 (HTLV-1) in oncogenesis: adult T-cell leukemia/lymphoma (ATLL)
2023, Critical Reviews in Clinical Laboratory SciencesHuman lymphotropic viruses: HTLV-1 and HTLV-2
2022, Clinical Virology: Third EditionPrevalence of Human T-Lymphotropic Virus Type 1 in Brain-Dead Organ Donors
2022, Archives of Clinical Infectious Diseases
Copyright © 1993 Published by Elsevier B.V.